SYN-TECH Chem. & Pharm. Statistics
Total Valuation
SYN-TECH Chem. & Pharm. has a market cap or net worth of TWD 4.17 billion. The enterprise value is 3.75 billion.
Market Cap | 4.17B |
Enterprise Value | 3.75B |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | Jul 19, 2024 |
Share Statistics
SYN-TECH Chem. & Pharm. has 44.59 million shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 44.59M |
Shares Change (YoY) | +0.04% |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.09% |
Float | 31.92M |
Valuation Ratios
The trailing PE ratio is 13.75.
PE Ratio | 13.75 |
Forward PE | n/a |
PS Ratio | 3.44 |
PB Ratio | 1.78 |
P/FCF Ratio | 90.47 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.15, with an EV/FCF ratio of 81.19.
EV / Earnings | 12.32 |
EV / Sales | 3.08 |
EV / EBITDA | 8.15 |
EV / EBIT | 11.54 |
EV / FCF | 81.19 |
Financial Position
The company has a current ratio of 3.71, with a Debt / Equity ratio of 2.65.
Current Ratio | 3.71 |
Quick Ratio | 2.26 |
Debt / Equity | 2.65 |
Debt / EBITDA | 0.14 |
Debt / FCF | 1.35 |
Interest Coverage | 66.23 |
Financial Efficiency
Return on equity (ROE) is 13.37% and return on invested capital (ROIC) is 8.23%.
Return on Equity (ROE) | 13.37% |
Return on Assets (ROA) | 7.13% |
Return on Capital (ROIC) | 8.23% |
Revenue Per Employee | 5.52M |
Profits Per Employee | 1.38M |
Employee Count | 220 |
Asset Turnover | 0.43 |
Inventory Turnover | 1.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.35% in the last 52 weeks. The beta is 0.13, so SYN-TECH Chem. & Pharm.'s price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | +3.35% |
50-Day Moving Average | 94.93 |
200-Day Moving Average | 88.21 |
Relative Strength Index (RSI) | 46.29 |
Average Volume (20 Days) | 75,855 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYN-TECH Chem. & Pharm. had revenue of TWD 1.22 billion and earned 303.94 million in profits. Earnings per share was 6.81.
Revenue | 1.22B |
Gross Profit | 457.55M |
Operating Income | 324.47M |
Pretax Income | 382.90M |
Net Income | 303.94M |
EBITDA | 456.44M |
EBIT | 324.47M |
Earnings Per Share (EPS) | 6.81 |
Balance Sheet
The company has 490.32 million in cash and 62.19 million in debt, giving a net cash position of 428.13 million or 9.60 per share.
Cash & Cash Equivalents | 490.32M |
Total Debt | 62.19M |
Net Cash | 428.13M |
Net Cash Per Share | 9.60 |
Equity (Book Value) | 2.35B |
Book Value Per Share | 52.64 |
Working Capital | 981.31M |
Cash Flow
In the last 12 months, operating cash flow was 314.48 million and capital expenditures -268.35 million, giving a free cash flow of 46.13 million.
Operating Cash Flow | 314.48M |
Capital Expenditures | -268.35M |
Free Cash Flow | 46.13M |
FCF Per Share | 1.03 |
Margins
Gross margin is 37.66%, with operating and profit margins of 26.70% and 25.01%.
Gross Margin | 37.66% |
Operating Margin | 26.70% |
Pretax Margin | 31.51% |
Profit Margin | 25.01% |
EBITDA Margin | 37.56% |
EBIT Margin | 26.70% |
FCF Margin | 3.80% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.74%.
Dividend Per Share | 3.50 |
Dividend Yield | 3.74% |
Dividend Growth (YoY) | 16.67% |
Years of Dividend Growth | 1 |
Payout Ratio | 44.01% |
Buyback Yield | -0.04% |
Shareholder Yield | 3.70% |
Earnings Yield | 7.27% |
FCF Yield | 1.11% |
Stock Splits
The last stock split was on August 3, 2012. It was a forward split with a ratio of 1.05.
Last Split Date | Aug 3, 2012 |
Split Type | Forward |
Split Ratio | 1.05 |